The Koch Clinical Investigator program provides physician-scientists a unique opportunity to participate in cutting-edge cancer research while continuing clinical work at oncology treatment centers in the Boston area. The investigators' dual role ensures that they remain involved in clinical practice, which in turn benefits KI researchers by providing a frontline view of clinical challenges in cancer treatment.
The selected individuals receive dedicated lab space and research support for their three- to five-year appointment, and work closely with faculty mentors at the Koch Institute. They spend between 10 and 50 percent of their time treating patients. Our current Clinical Investigator is Peter Ghoroghchian. Salil Garg will become the Koch Institute's Clinical Investigator beginning in January 2018.
Koch Institute Research Fellows are early career scientists with independent NIH Early Investigator funding. The KI makes a serious commitment to its Research Fellows by providing separate lab space, access to equipment and resources, and mentoring opportunities. Our current KI Research Fellow is Dennis Zimmermann.